Cytogenetic risk stratification combined with minimal residual disease status influences the therapeutic outcome and prognosis of multiple myelomas

J Jianping Mao L Lianguo Xue H Haiqing Wang (State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences) H Hang Zhou Y Yuanxin Zhu T Tao Jia (School of Chemistry and Chemical Engineering) Z Zhimei Cai L Lina Zhao (Beijing Key Laboratory of Big Data Innovation and Application for Skeletal Health Medical Care) L Lidong Zhao Y Ying Wang J Juan Wang (Department of Chemical and Biomolecular Engineering)